Zosano Pharma, a specialty pharmaceutical company, has reported positive results from its Phase II study of the ZP-PTH rapid delivery patch for the treatment of osteoporosis. The study
Dr Fetzer will succeed Alan Crane, who has been named chairman of the board of directors. In addition to serving as chairman of Cerulean, Mr Crane will assume
Under the new contract, members of Aetna’s network-based plans will be able to receive covered benefits, at in-network rates, from St Dominic-Jackson Memorial Hospital and Mississippi Baptist Medical
Ms Tan joins Sinobiopharma from Organon Pharmaceutical, Netherlands. Ms Tan served as a China-based unit marketing director for Organon, which was recently sold to Schering-Plough. Prior to Organon,
According to NMT Medical, the STARFlex implant can be placed in the heart to close the ventricular septal defects (VSD) using a catheter during a minimally invasive procedure,
ChemGenex placed 23.25 million fully paid ordinary shares in the company at an issue price of A$0.43 per share to raise gross proceeds of A$10 million. In addition
This Phase IIa randomized, double-blind, placebo-controlled study will evaluate the antiviral activity, safety and pharmacokinetics of TAK-652 by enrolling 40 therapy-experienced, CCR5-naive HIV-1-infected patients into one of four
Cephalon, a biopharmaceutical company, has reported positive results from a Phase III clinical trial of Nuvigil tablets as a treatment for excessive sleepiness associated with jet lag disorder.
Asterand has reported that its partner BTG plans to advance BGC20-1531, a novel EP4 receptor antagonist for the treatment of migraine headaches, to Phase IIa studies in the
Adcock Ingram will reportedly make the payment in cash, with an option for shareholders to re-invest up to 25% in the combined company. The Adcock Ingram offer equates
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.